Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

BIO Notebook: Califf On RWE, Industry Execs On Growing Therapeutic Areas, And More

Jun 06 2024

• By Scrip Team

BIO 2024 Day 4 — • Source: Shutterstock

Related Content

Medicare Price Negotiations: Competitors’ Net Prices, Clinical Benefit Are ‘Starting Point’ For Initial Offer

Mar 16 2023

UPDATED: US FDA Has People Working At CMS To Help Implement Inflation Reduction Act

Feb 21 2023

BMS Speeds Expansion Into Neuroscience With $14bn Karuna Buy

Dec 22 2023

Roche Looks To Muscle Into Obesity Market With $2.7bn Carmot Buyout

Dec 04 2023

Eyebrows Raised As Roche Inks Cardiovascular Pact With Alnylam

Jul 24 2023

Finance Watch: Alto, Fractyl Bring IPO Count To Four, So Far, In 2024

Feb 05 2024

Related Companies

Roche Holding AG

Carmot Therapeutics Inc.

Alnylam Pharmaceuticals Inc.

Alto Neuroscience

Cerevel Therapeutics Holdings, Inc.

Bristol Myers Squibb Company

Karuna Therapeutics, Inc.

Merck & Co., Inc.

Additional Topics

Real-World Evidence Business Strategies Deals Financing Policy Commercial BIO BioPharmaceutical

More from BIO

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window